Greenland shark longevity requires coordinated DNA repair and immune regulation pathways

Research synthesis from comparative genomics of the Greenland shark (Somniosus microcephalus), which lives 400+ years with negligible senescence.
Core Finding: The shark genome shows coordinated expansion in two critical pathways:
- 81 duplicated genes for double-strand DNA break repair, including functionally altered TP53 tumor suppressor
- Expanded NF-κB signaling families (TNF, TLR, LRRFIP) regulating inflammation, immunity, and apoptosis
Druggable Human Homologs:
- p53 pathway: MDM2 inhibitors (Nutlin-3, APR-246) can reactivate mutant p53
- NF-κB pathway: Proteasome inhibitors (bortezomib), TNF inhibitors, glucocorticoids
- Protein homeostasis: mTOR inhibitors (rapamycin) enhance autophagy
Key Insight: Longevity appears to require simultaneous enhancement of BOTH DNA repair capacity AND controlled inflammatory responses—not amplification of single pathways. This suggests combination therapies co-targeting p53 and NF-κB might outperform monotherapies, though such combinations remain largely unexplored in human aging research.
Sources: Lifespan.io, ScienceAlert, PubMed, Smithsonian Magazine coverage of shark longevity research.